Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Ovid Therapeutics Inc (OVID)

Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results GlobeNewswire - Tue May 13, 7:00AM CDT

OVID : 0.3053 (+3.53%)
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference GlobeNewswire - Wed Apr 2, 7:00AM CDT

OVID : 0.3053 (+3.53%)
Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire - Tue Mar 11, 7:00AM CDT

OVID : 0.3053 (+3.53%)
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors GlobeNewswire - Mon Mar 3, 7:00AM CST

OVID : 0.3053 (+3.53%)
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference GlobeNewswire - Thu Feb 27, 7:00AM CST

OVID : 0.3053 (+3.53%)
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference GlobeNewswire - Wed Feb 5, 7:00AM CST

OVID : 0.3053 (+3.53%)
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting GlobeNewswire - Mon Dec 2, 2024

OVID : 0.3053 (+3.53%)
Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 2024

OVID : 0.3053 (+3.53%)
Ovid Therapeutics to Host Investor Event GlobeNewswire - Thu Oct 31, 2024

OVID : 0.3053 (+3.53%)
Buy, Sell - Buy enter button by Ardasavasciogullari via iStock
3 'Strong Buy'-Rated Stocks to Buy Now on the Dip Barchart - Wed Jul 31, 2024

These outstanding growth stocks are worth buying on the dip.

$SPX : 5,916.93 (+0.41%)
OVID : 0.3053 (+3.53%)
GEHC : 72.91 (+0.10%)
GD : 278.51 (+2.89%)
AMZN : 205.17 (-2.42%)
TAK : 14.00 (+2.12%)

Barchart Exclusives

Dividend Aristocrats Offer Safety in Market Storms. Buy These 2 Top-Rated Stocks Now. Barchart - Thu May 15, 6:30PM CDT
Dividend Aristocrats bring the calm with steady paychecks, making these two 'Strong Buy'-rated stocks worth a second look here. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot